Is RAONF or QYLD a better dividend investment in 2026?

RAONF currently yields 76.92% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: RAONF offers higher current income.

What is the dividend yield difference between RAONF and QYLD?

RAONF has a forward dividend yield of 76.92% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 65.00 percentage points.

Home › Compare › RAONF vs QYLD

RAONF vs QYLD: Dividend Comparison 2026

RAONF yields 76.92% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RAONF wins by $1.42M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RAONF

● Live price

76.92%

Share price

$2.60

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.45M

Annual income

$406,212.55

Full RAONF calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — RAONF vs QYLD

📍 RAONF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RAONF	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RAONF + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RAONF pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RAONF

Annual income on $10K today (after 15% tax)

$6,538.46/yr

After 10yr DRIP, annual income (after tax)

$345,280.67/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, RAONF beats the other by $340,470.25/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RAONF + QYLD for your $10,000?

RAONF: 50%QYLD: 50%

100% QYLD50/50100% RAONF

Portfolio after 10yr

$735.2K

Annual income

$205,935.93/yr

Blended yield

28.01%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RAONF buys

QYLD buys

No recent congressional trades found for RAONF or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRAONFQYLD

Forward yield	76.92% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.45M	$25.4K ✓
Annual income after 10y	$406,212.55 ✓	$5,659.31
Total dividends collected	$1.25M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: RAONF vs QYLD ($10,000, DRIP)

Year	RAONF Portfolio	RAONF Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$18,392	$7,692.31	$10,352	$1,192.36	+$8.0K → RAONF
2	$32,902	$13,222.36	$10,830	$1,347.57	+$22.1K → RAONF
3	$57,311	$22,106.15	$11,460	$1,539.07	+$45.9K → RAONF
4	$97,310	$35,987.08	$12,275	$1,777.84	+$85.0K → RAONF
5	$161,228	$57,105.82	$13,323	$2,078.95	+$147.9K → RAONF
6	$260,939	$88,425.56	$14,667	$2,463.34	+$246.3K → RAONF
7	$412,955	$133,749.94	$16,396	$2,960.57	+$396.6K → RAONF
8	$639,683	$197,821.28	$18,631	$3,612.97	+$621.1K → RAONF
9	$970,847	$286,385.73	$21,548	$4,482.15	+$949.3K → RAONF
10	$1,445,019	$406,212.55	$25,398	$5,659.31	+$1.42M → RAONF

RAONF vs QYLD: Complete Analysis 2026

RAONF — Stock

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.

Full RAONF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this RAONF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RAONF vs SCHD RAONF vs JEPI RAONF vs O RAONF vs KO RAONF vs MAIN RAONF vs XYLD RAONF vs JEPQ RAONF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.